Mediplex 675 - Liq 8 X Liquid is a Health Canada–registered human drug (DIN 02116960) held by Mediherb Inc., containing Anacardium Orientale. Health Canada lists its status as Cancelled Post Market (status date 31 Jul 2008). Nexara Health has matched 23 registrations of Anacardium Orientale across 2 other regulated markets.
Health Canada registration
| DIN | 02116960 |
|---|---|
| Brand name | Mediplex 675 - Liq |
| Active ingredient | Anacardium Orientale |
| Strength | 8 X |
| Dosage form | Liquid |
| Route | Oral |
| Company | Mediherb Inc. |
| Status | Cancelled Post Market — 31 Jul 2008 |
| Class | Human |
| ATC | |
| AHFS | 92:02.00* ; See footnote |
| Regulator record | Health Canada DPD entry · Product monograph |
Anacardium Orientale registered in other markets
23 registrations of the same molecule in 2 national registries outside Canada (first 10 shown, exact strength and form first). Each row is taken from the regulator's own published list; status is shown as the registry reports it.
| Country | Product | Marketing authorisation holder | Strength | Form | Status | Registry |
|---|---|---|---|---|---|---|
| Netherlands | Anacardium orientale | BOIRON (Messimy) | 4 DH t/m 60 DH#2 CH t/m 200 CH#6 K t/m 100.000 K#1 LM t/m 30 LM | Globuli | Uitsluitend apotheek of drogist | EU national register |
| Netherlands | Anacardium orientale | BOIRON (Messimy) | 4 DH t/m 60 DH#2 CH t/m 200 CH#6 K t/m 100.000 K#1 LM t/m 30 LM | Uitsluitend apotheek of drogist | EU national register | |
| United States | Anacardium Orientale | Hahnemann Laboratories, INC. | Pellet | listed | FDA NDC | |
| United States | Anacardium Orientale | Hahnemann Laboratories, INC. | Pellet | listed | FDA NDC | |
| United States | Anacardium Orientale | Hahnemann Laboratories, INC. | Pellet | listed | FDA NDC | |
| United States | Anacardium Orientale | Hahnemann Laboratories, INC. | Pellet | listed | FDA NDC | |
| United States | Anacardium Orientale | Hahnemann Laboratories, INC. | Pellet | listed | FDA NDC | |
| United States | Anacardium Orientale | Hahnemann Laboratories, INC. | Pellet | listed | FDA NDC | |
| United States | Anacardium Orientale | Hahnemann Laboratories, INC. | Pellet | listed | FDA NDC | |
| United States | Anacardium Orientale | Hahnemann Laboratories, Inc. | Pellet | listed | FDA NDC |
See every manufacturer of Anacardium Orientale worldwide →
Sourcing through Nexara Health
Nexara Health is a Health Canada–licensed wholesaler (DEL #3-002896) in Winnipeg. This DIN is not currently marketed in Canada. The registrations above show which regulated markets hold an equivalent presentation that can be sourced for clinical comparator use or on a named-patient basis under Health Canada's Special Access Programme. Request a quote or read how named-patient and foreign-pack supply works in Canada.
Frequently asked questions
Is Mediplex 675 - Liq (DIN 02116960) marketed in Canada?
No. Health Canada lists DIN 02116960 as Cancelled Post Market as of 31 Jul 2008.
Who holds the Canadian licence for this product?
Mediherb Inc. is the company of record in the Health Canada Drug Product Database.
Is Anacardium Orientale registered outside Canada?
Yes — Nexara Health has matched 23 registrations in 2 other markets (see the table above).
Where does this data come from?
Health Canada Drug Product Database (DPD), DIN 02116960, status date 2008-07-31; national medicine registries: EU national register, FDA NDC. Nexara Health re-checks these sources weekly and shows the last verification date at the top of the page.
Source: Health Canada Drug Product Database (DPD), DIN 02116960, status date 2008-07-31; national medicine registries: EU national register, FDA NDC.
Health Canada Drug Product Database (DPD), DIN 02116960, status date 2008-07-31; national medicine registries: EU national register, FDA NDC. Last reviewed 2026-09-16. Nexara Health is a licensed wholesaler and supplies licensed entities only; consumer orders are routed to a partner pharmacy.